Clinical manifestation < Clinical manifestations < Clinical markers

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Clinical manifestations

Number of relevant bibliographic references: 108.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001147 (2013)	Guillaume Pouessel [France] ; Antoine Deschildre [France] ; Muriel Le Bourgeois [France] ; Jean-Marie Cuisset [France] ; Benoit Catteau [France] ; Chantal Karila [France] ; Véronique Nève [France] ; Caroline Thumerelle [France] ; Pierre Quartier [France] ; Isabelle Tillie-Leblond [France]	The lung is involved in juvenile dermatomyositis
001151 (2013)	L. O. Damian ; I. Felea ; S.-P. Simon ; M. Lupse ; C. Bodolea [Roumanie] ; L. Ghib ; R. Mocanu ; S. Rednic	THU0394 Macrophage activation syndrome in adult onset still’s disease: A single center experience
001152 (2013)	J. J. Kim [Corée du Sud] ; K. H. Jung ; Y. B. Joo [Corée du Sud] ; C. B. Choi [Corée du Sud] ; Y. K. Sung [Corée du Sud] ; J. B. Jun [Corée du Sud] ; T. H. Kim [Corée du Sud] ; S. C. Bae [Corée du Sud] ; D. H. Yoo [Corée du Sud]	THU0393 The clinical observational study of adult onset still’s disease in a large cohort of korean patients
001153 (2013)	I. Pérez-Martín ; R. Blanco ; N. Ortego ; V. Llorens-Bellés [Espagne] ; A. Adán [Espagne] ; A. Olivé ; W. A. Sifuentes Giraldo [Espagne] ; S. González [Espagne] ; C. Bejerano ; M. C. González-Vela ; M. A. González-L Pez ; H. Fernández-Llaca ; A. Oterino ; M. J. Sedano ; M. Agudo ; A. Corrales ; V. M. Martínez-Taboada ; M. A. G Nzalez-Gay	THU0391 Anti-TNF therapy in severe and refractory sarcoidosis: Multicenter study of 25 patients
001195 (2013)	A. Petit [France] ; O. E. Dadzie	Multisystemic diseases and ethnicity: a focus on lupus erythematosus, systemic sclerosis, sarcoidosis and Behçet disease
001201 (2013)	D. C. Ferreira [Brésil] ; G. Nogueira ; V. A. Cancio ; F. S. Cavalcante ; P. Godefroy ; D. S. C. Sousa ; W. Hespanhol ; K. R. N. Dos Santos ; M. A. B. Cavalcante	Loss of lingual sensitivity and slightly increased size signaling schwannoma in a patient with mixed conjunctive tissue disease
001249 (2013)		Abstracts
001315 (2012)	Linnette L Pez-L Pez [Porto Rico] ; Noridza Rivera-Rodríguez [Porto Rico] ; Luis M. Vilá [Porto Rico]	Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus
001573 (2011)	M. Dugar [Australie] ; S. Cox ; V. Limaye ; P. Blumbergs ; P. J. Roberts-Thomson [Australie]	Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodies
001630 (2010)	Maija-Leena Eloranta [Suède] ; Karin Franck-Larsson [Suède] ; Tanja Lövgren [Suède] ; Sebastian Kalamajski [Suède] ; Anders Rönnblom [Suède] ; Kristofer Rubin [Suède] ; Gunnar V. Alm [Suède] ; Lars Rönnblom [Suède]	Type I interferon system activation and association with disease manifestations in systemic sclerosis
001753 (2010)		2.7. Systemic lupus erythematosus, Sjögren's and antiphospholipid syndrome ‐ clinical aspects, comorbidities and complications
001823 (2009)		Reporting On Adverse Clinical Events
001838 (2009)	Antonio Romo De Vivar Chavez [États-Unis] ; William Buchser ; Per H. Basse ; Xiaoyan Liang [États-Unis] ; Leonard J. Appleman ; Jodi K. Maranchie ; Herbert Zeh ; Michael E. De Vera [États-Unis] ; Michael T. Lotze	Pharmacologic Administration of Interleukin‐2
001890 (2009)	As Al Arfaj [Arabie saoudite] ; N. Khalil [Arabie saoudite]	Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia
001A02 (2008)	Am Negr N [Porto Rico] ; Mj Molina [Porto Rico] ; Am Mayor [Porto Rico] ; Ve Rodríguez [Porto Rico] ; Lm Vilá [Porto Rico]	Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico
001A32 (2008)		Abstracts
001A93 (2007)	A. M. Bertoli [Porto Rico] ; L. M. Vila [États-Unis] ; M. Apte [États-Unis] ; B. J. Fessler [États-Unis] ; H. M. Bastian [États-Unis] ; J. D. Reveille [États-Unis] ; G. S. Alarcon [États-Unis]	Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
001A94 (2007)	T. Heller ; M. Ahmed [Arabie saoudite] ; A. Siddiqqi [Arabie saoudite] ; C. Wallrauch [Arabie saoudite] ; S. Bahlas [Arabie saoudite]	Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population
001B42 (2007)	Joerg Wenzel [Allemagne] ; Thomas Tüting [Allemagne]	Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches
001B50 (2007)	F. Burling [Nouvelle-Zélande] ; J. Ng [Nouvelle-Zélande] ; H. Thein [Nouvelle-Zélande] ; J. Ly [Nouvelle-Zélande] ; M. R. Marshall [Nouvelle-Zélande] ; P. Gow [Nouvelle-Zélande]	Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort
001B53 (2007)	G. Castellino [Italie] ; F. Corallini [Italie] ; F. Trotta [Italie] ; P. Secchiero [Italie]	Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Clinical manifestations" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Clinical manifestations" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Clinical manifestations
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021